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ABSTRACT

KERATIN 8/18 FILAMENTS: POTENTIAL MODULATORS OF DEATH
SIGNALING IN OVARIAN GRANULOSA CELLS

BY
Sarah E. Kinsman
University of New Hampshire, Durham, December 2012

Granulosa cell apoptosis is associated with follicular atresia; but the
cellular mechanisms that drive this process, especially its cell specificity, are
relatively unknown. Here, we determined that cultured granulosa cells
abundantly express K8/K18 filaments and inhibition of protein synthesis
enhances Fas-induced apoptosis. In this context, the roles of cFLIP, ERK1/2
and Akt are minimal but conversely, K8/K18 filaments have a prominent role
in granulosa cell resistance to Fas-induced apoptosis. Keratin 8/18 filaments
in granulosa cells provide a plausible mechanism to avoid Fas-induced
apoptosis and this mechanism potentially involves the synthesis of labile
proteins. The existence of K8/K18 filaments in granulosa cells has relevance

to follicular atresia and the selection of follicles for ovulation. These insights
may have bearing on future therapeutic strategies to improve female fertility.

ix

INTRODUCTION

Implications of Dairy Infertility
Animal infertility is an economic concern of today’s agricultural
industry. The modern dairy cow is now producing more milk than ever before,
essentially doubling output from 1951 to 1996 (Butler, 1998), but this increase
in milk production has been accompanied by an equally-striking decline in
fertility (Butler and Smith, 1989; Lucy, 2001). To make matters worse,
farmers are now faced with the challenge of declining cow numbers and
agricultural land (Dobson et al., 2007). Annual milk production per cow in the
United States is projected to reach over 14 tons in 2050 (Santos et al., 2010),
placing greater pressure on the metabolic needs (especially the reproductive
needs) of the animal. Expanding our understanding of fertility at the cellular
level will benefit the cow, the dairy farmer and ultimately, the dairy industry, if
it leads to improvement in reproductive efficiency.
Negative Energy Balance and Infertility
At calving, high-milk producing cows enter a metabolic state referred to
as negative energy balance (NEBAL) because nutritional intake of the cow is
1

unable to meet the energy requirements for milk production. The occurrence
of NEBAL mobilizes the cows’ body reserves (i.e., fat and muscle), which
collectively has a negative impact on body condition, health and reproductive
function of the cow. These metabolic changes disrupt the endocrine system
as a whole, ultimately hindering ovarian activity (Beam and Butler, 1997;
Lucy, 2001). During NEBAL, serum levels of luteinizing hormone (LH), insulin
and insulin-like growth factor (IGF-I) are depleted, which impairs follicle
maturation and delays ovulation (Beam and Butler, 1997; Butler, 2000; Lucy,
2002). In addition, the metabolic by-products of NEBAL (e.g., non-essential
fatty acids, ketones and urea) infiltrate the follicular fluid of ovarian follicles,
adversely affecting egg (oocyte) quality (Leroy, 2004) and, thus, further
compromising animal fertility. For the high-milk producing cow, NEBAL and a
decline in body condition are directly associated with a higher incidence of
delayed ovulation, reduced conception rates, and a greater occurrence of
embryonic loss (Lucy, 2002).
The Ovary
Ovarian Structures
The ovary in females is the primary reproductive structure responsible
for influencing reproductive cyclicity through its secretion of steroids and for
producing gametes (oocytes) for purposes of conception and pregnancy. The
ovary consists of two notable endocrine structures; the follicle and the corpus
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luteum. Both of these structures develop, mature and regress during the
course of a single reproductive cycle.
The Ovarian Follicle
Within each ovarian follicle there is the female gamete, the oocyte
(egg), which is surrounded by two other somatic cell types, the granulosa and
the theca cells (reviewed by Aerts and Bols, 2010). Granulosa cells are
characterized as either membrana granulosa cells, which constitute the
majority of cells within the interior of the follicle, or the cells that surround the
oocyte in a mature follicle, which are known as the cumulus oophorus (Figure
1). Theca cells comprise the supportive cells surrounding the follicle,
separated from the granulosa cells by a basement membrane. The theca
cells can be further subdivided into theca interna and theca externa based
upon their vascularity and relative proximity to the basement membrane of the
follicle (Young and McNeilly, 2010) (Figure 1).

In response to systemic

luteinizing hormone (LH), theca interna cells synthesize androgens, such as
androstenedione, derived from the precursor molecule cholesterol. Thecaderived androgens diffuse across the basement membrane of the follicle to
the granulosa cells, where follicle-stimulating hormone (FSH), also secreted
systemically, directs the conversion of androgens to estradiol (Fortune, 1994).
This “shared synthesis” of steroids between the theca and granulosa layers of
maturing follicles is referred to as the “two-cell theory” and was first described
by Roger Short and colleagues (Short, 1962).

3

Theca
externa
Theca
interna

Antrum

Cumulus oophorus —\
granuisoa cells
Mem brana
granulosa

Figure 1 Representative diagram of ovarian follicle structure and morphology.
Folliculoqenesis
Anatomically, ovarian follicles are divided into four classifications
according to relative developmental stage: primordial, primary, secondary and
tertiary follicles (Figure 2). Primordial follicles contain a non-growing oocyte
surrounded by squamous epithelial granulosa cells, which range from 25-50
pm in diameter (Figure 2a). Primary follicles contain a growing oocyte
surrounded by cuboidal granulosa cells, and range in diameter from 35-70 pm
(Figure 2b). Secondary follicles are roughly doubled in size (70-120 pm), and
contain multiple layers of granulosa cells (Figure 2c). Lastly, tertiary follicles
are largest follicles (£ 5 mm in diameter) with a defined cumulus oophorus
surrounding the mature oocyte and antral space enclosed by membrana
granulosa and vascularized theca cells (Figure 2d-f)(Pedersen and Peters,
1968; Gougeon and Chainy, 1987; Fairetal., 1997; Myers etal., 2004;
4

Kacinskis et al., 2005; Hunzicker-Dunn and Maizels, 2006; Rodgers and
Irving-Rodgers, 2010).

Figure2 Follicle Classification, (a) primordial, (b) primary, (c) secondary, (d) early
tertiary, (e) tertiary, and (f) late tertiary follicles. Bar = 20pm. (Myers et al., 2004)

The Corpus Luteum
Another structure characteristic of the mammalian ovary is the corpus
luteum. The corpus luteum (CL; Latin for yellow body) is a transient
endocrine structure responsible for the maintenance of pregnancy through its
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secretion of progesterone (Niswender et al., 1994; Niswender et al., 2000;
Davis and Rueda, 2002). Briefly, following the process of ovulation, the
remaining granulosa and theca cells of the recently ovulated follicle
differentiate to form the so-called “luteal cells” comprising the CL. In some
species, these luteal cells retain size characteristics reminiscent of their
precursor theca and granulosa cells, but they are generally referred to as
simply small (<20 pm) and large (20-30 pm) steroidogenic luteal cells based
upon their relative diameter (Alilia and Hansel, 1984; McCracken et al., 1999).
There are distinguishing physiological characteristics of the small and large
luteal cells, though, such as progesterone synthetic capability, sensitivity to
LH stimulation, etc., but these aspects of distinction are beyond the scope of
the current literature review. Suffice-it-to-say that progesterone secretion by
both types of luteal steroidogenic cells facilitates the maintenance of
pregnancy by preparing the. uterus for implantation and preventing
subsequent ovulations (Kasa-Vubu et al., 1992; Davis and Rueda, 2002). In
the event that conception fails, or a pregnancy is lost mid-gestation, the CL
promptly undergoes regression, progesterone secretion declines, and the
resumption of follicular development and ovulation for the next reproductive
cycle occurs.
The Estrous Cycle
In the cow, the duration of the reproductive cycle (estrous cycle) is
typically 21 days, but may range from 17-28 days. Each estrous cycle begins
with the onset of ovulation (d=0), followed by an extended luteal phase (days

1-17) and a brief follicular phase (days 18-21) in non-pregnant animals.
Similar to horses and humans, cows typically ovulate only a single oocyte per
cycle. However, the process leading to ovulation in these species is
distinguished by successive, temporal waves of follicular development,
defined as “follicular waves” (Ginther et al., 1989), in which groups of follicles
grow to yield a single, mature follicle for ovulation. Typically two to three
waves of follicular growth occur per cycle, in which each wave consists of a
group or cohort of follicles selected to mature, or undergo atresia, during the
wave. This process of follicular waves ultimately results in the selection of a
single follicle for ovulation (Fortune et al., 1991; Lucy et al., 1992).
Follicular waves during the bovine estrous cycle are characterized by
the recruitment, selection and dominance, or atresia, of ovarian follicles
(Hogden, 1982). Recruitment and growth of the cohort of follicles within a
wave occurs in response to follicle stimulating hormone (FSH) from the
anterior pituitary gland (Walters and Schallenberger, 1984). Generally, one
follicle of the cohort is ultimately selected to continue to grow and becomes
the dominant follicle, whereas the remaining follicles of the cohort die off in a
process referred to as follicular atresia. The onset of dominance is identified
as the first day the dominant follicle is 1-2 mm larger than the next largest
follicle in the cohort, and all other follicles in the cohort (subordinate follicles)
cease growth, as determined by ultrasonographic measures (Hodgen, 1982).
The dominant follicle of the first follicular wave may ovulate, but
typically undergoes atresia because of high systemic concentrations of

progesterone attributed to the presence of the recently formed CL. A second
or third wave of follicular development ensues, also yielding a dominant
follicle which eventually becomes the preovulatory follicle (Savio et al., 1988).
Increased plasma estradiol produced by the preovulatory follicle generates a
positive feedback loop to the anterior pituitary, triggering a robust surge of
luteinizing hormone (LH) secretion and ovulation. Following ovulation,
remnants of the ruptured follicle (i.e., granulosa and theca cells) undergo
differentiation to form the corpus luteum (CL). In the absence of fertilization,
the CL persists for only 16-17 days after ovulation, undergoes regression
(luteolysis), which then triggers the onset of the next estrous cycle.
As described above, dairy cows typically have two to three follicular
waves per estrous cycle (Rajakoski, 1960; Ireland and Roche, 1983)
Conversely, the loss of follicles (follicular atresia), the absence of ovulation,
and premature regression of the CL are all issues contributing to infertility in
dairy cows. For purposes of this review, we will focus only on those
mechanisms directly pertaining to follicular atresia.
Follicular Atresia and Apoptosis
Throughout the lifespan of most female mammals, over 99% of ovarian
follicles are lost by degenerative and hormonally controlled processes
collectively called follicular atresia (Erickson, 1966). Tilly and Hughes (1991)
were among the first investigators to propose apoptosis (programmed cell
death) of granulosa cells as a direct cellular mechanism contributing to
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follicular atresia (Hughes et al., 1991; Tilly et al., 1991). Programmed cell
death is specific, but the external factors controlling this specificity are
relatively unknown. It is generally accepted that crosstalk within cells
between cellular survival and death signals determine the fate of ovarian
follicles (Amsterdam et al., 2003). However, these survival and death signals
can be induced by a variety of external endocrine, paracrine, and autocrine
factors, or any combination of the three (Amsterdam et al., 1999). Here we
provide a general overview of the survival signals and death signals that
affect granulosa cell fate within follicles, and some of the factors that influence
these signals.
Survival Signals
The growth of follicles, or folliculogenesis, depends upon hormonal
signals from the anterior pituitary to direct theca and granulosa cell growth
while inhibiting apoptosis (Quirk et al., 2004). The gonadotropins, LH and
FSH, are required at the antral stage of folliculogenesis to direct selection of
tertiary follicles. During this time, one follicle of the cohort establishes its
presence and becomes dominant, while subordinate follicles undergo atresia
(Webb et al., 2007). One aspect influencing selection of the dominant follicle
is the fact that FSH stimulates estradiol production by granulosa cells within
this follicle, establishing its further growth and dominance (reviewed by
Matsuda et al., 2012). For their part, the granulosa cells of selected follicles
also secrete survival signals that promote growth (Matsuda et al., 2012).
These signals include insulin-growth factor I (IGF-I) (Hirshfield, 1991; Webb et

al., 2007). IGF-I promotes mitosis of granulosa cells, estradiol production and
responsiveness to further FSH and LH stimulation by increasing gonadotropin
receptor expression (Guthrie et al., 1998; Quirk et al., 2004). Paracrine and
autocrine effects of estradiol seceretion by granulosa cells, in concert with
IGF-I secretion, further enhance mitosis and differentiation of granulosa cells,
while preventing apoptosis (Quirk et al., 2004; reviewed by Palter, 2011). In
subordinate follicles undergoing atresia these survival signals diminish, the
granulosa cells lose functionality, and ultimately undergo apoptosis. A loss of
estradiol and IGF-I secretion in genetic knockout mice, for instance, triggers
granulosa cell apoptosis, abnormal follicular development, and infertility
(Baker etal., 1996; Britt et al., 2000; Dupont etal., 2000; Zhou et al., 1997).
Other factors influencing granulosa cell fate include epidermal growth factor
(EGF), basic fibroblast growth factor (bFGF), interleukin-6 (IL-6) and IL-13
(Chun etal., 1995; Guthrie etal., 1998; Lynch et al., 2000; Tilly etal., 1992),
which stimulate granulosa cell growth and proliferation, enhance
folliculogenesis, and promote follicle selection and dominance.
Death Signals (Apoptosis)
Apoptosis is a biological process responsible for controlling cell
numbers and tissue size, while concurrently providing protection from
invasive cells (Tschopp et al., 1998; reviewed by Hengartner, 2000; Peter,
2004). The term “apoptosis” was first coined by John Foxton Ross Kerr in the
1970’s who defined the process as consisting of two stages: 1) the formation
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of apoptotic bodies, and 2) the phagocytosis of apoptotic bodies (Kerr et al.,
1972).
All cells are equipped with the machinery to trigger apoptosis but most
often the process is avoided by the actions of survival signals (Alberts et al.,
2002; Kanamaru et al., 2012; Peter and Krammer, 1998). Apoptosis is
principally executed by a class of intracellular cysteine proteases known as
caspases, which become activated by a variety of intracellular (intrinsic
pathway) or extracellular (extrinsic pathway) influences (Fernandes-Alnemri
et al., 1995). All caspases are initially translated as inactive proteins
containing a pro-domain (zymogens). Most caspases are commonly
activated by: 1) other nearby caspases (caspase-8) or 2) autocatalytic
cleavage by another active caspase (caspase cascade; caspase-3, -6 and -7)
(Thornberry et al., 1997; Hengartner, 2000). Active caspases are proteolytic
and cleave proteins having aspartate residues, inhibiting their biological
function (Hengartner, 2000).
Intrinsic Pathway
The intrinsic (mitochondrial) apoptotic pathway integrates pro-apoptotic
and anti-apoptotic signals within the target cell by apoptotic regulator proteins
of the bcl-2 family (Quirk et al., 2004). The bcl-2 family includes pro-apoptotic
proteins (Bax, Bad, Bim, Bid, Bok, Bcl-2-short) and anti-apoptotic proteins
(Bcl-2, Bcl-2-long, Bcl-w) (Antonsson and Martinou, 2000; Quirk et al., 2004).
In response to an insult or stress, the intrinsic mitochondrial pathway
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becomes activated, releasing cytochrome c into the cytoplasm. Cytochrome
c, apoptosis-activating factor (Apaf)-1 and pro-caspase 9 form an
apoptosome complex (Li et al., 1997). This complex cleaves pro-caspase-9
to its activate form, which then activates caspase-3 and other downstream
caspases (Hengartner, 2000). Other mitochondrial pro-apoptotic proteins
include Smac-diablo and apoptosis inducing factor (AIF) (Susin et al., 19992;
Du et al., 2000; Verhagen et al., 2000).
Extrinsic Pathway
Signaling molecules responsible for inducing apoptosis via the extrinsic
pathway are mediated by transmembrane death receptors (Barnhart et al.,
2003; Thornburn, 2004). Several types of cytokines induce the extrinsic
pathway in a variety of cells (e.g., Fas ligand, tumor necrosis factor, TRAIL,
etc.), but for purposes of the current discussion about granulosa cells, we will
focus only on the Fas ligand-Fas-mediated pathway. The Fas receptor is a
42-52 kDa member of the tumor necrosis factor (TNF) super family and is
thought to trigger the apoptotic death of granulosa cells during follicular
atresia (Matsuda-Minehata et al., 2006; Porter et al., 2000; Vickers et al.,
2000).

The Fas-induced apoptotic pathway is characterized by the expression
of the cytokine, Fas ligand (FasL; CD95), which binds to Fas receptor,
causing trimerization of the ligand-receptor complex. Within the target cell, an
adaptor protein known as the Fas-Associated Death Domain (FADD) protein
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binds to the cytoplasmic region of the Fas receptor, specifically the “death
domain” region of Fas. This interaction between Fas and FADD results in the
binding of pro-caspase 8, forming the Death-Inducing Signaling Complex
(DISC). Formation of the DISC results in cleavage of pro-caspase 8 to
activated caspase 8, initiating a signaling cascade that leads to apoptosis of
the cell (Thornburn, 2004).
Counteracting the effects of pro-caspase-8 activation and the
downstream stimulation of apoptotic mechanisms is the molecule known as
cellular flice inhibitory protein (cFLIP) (Hu etal., 1997). Originally discovered
as a viral apoptotic inhibitor (Thome et al., 1997), cFLIP is a labile, antiapoptotic protein that competes with procaspase-8 for binding to FADD and
the formation of the DISC. The structure of cFLIP is identical to pro-caspase8 but it lacks the enzymatic region to trigger downstream death effects
(Micheau, 2003; Oztiirk et al., 2012). The structural similarities between
cFLIP and pro-caspase-8 enable cFLIP to competitively bind to FADD,
preventing pro-caspase-8 binding, and thus inhibiting pro-caspase-8
cleavage, activation and downstream apoptotic signaling.
Survival Signaling Pathways
Growth of ovarian follicles depends upon survival signaling pathways
within granulosa cells to override potential death signals and prevent the
occurrence of apoptosis. Two survival pathways of particular interest in
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granulosa cells include the Ras/mitogen-activated protein kinase (MAPK) and
the phosphoinositide 3'-OH kinase (PI3K)/Akt pathways.
The MAPK/ERK Pathway
The MAPK pathway contributes to cell survival, proliferation, and
differentiation of granulosa cells (Chang and Karin, 2001; Pearson et al.,
2001). Mammalian MAPK are divided into four classes- the extracellularsignal regulated kinases (ERK1/2), Jun amino-terminal kinases (JNK1/2/3),
p38 proteins and ERK5 (Peter and Dhanasekaran, 2003; Shiota et al., 2003).
ERK1/2 and ERK5 are survival kinases (Nishimoto and Nishida, 2006),
whereas p38 and JNK are implicated as apoptotic kinases (Fey et al., 2012).
The MAPK pathways are activated in response to extracellular stimuli;
the ERK pathways are activated by growth factors, while the JNK and p38
pathways are activated by cytokines and cellular stress (Ip and Davis, 1998).
All of these signaling cascades involve activation of intracellular MAP kinase
kinases that then phosphorylate either the MAP kinases ERK1/2, JNK, p38 or
ERK5. Phosphorylated MAPK act as second messengers and translocate to
the nucleus where they regulate gene expression of survival and apoptotic
proteins (Zeng et al., 2005). Ultimately, the fate of the cell is determined by
the balance between survival and apoptotic signals; i.e. if survival signals
outweigh apoptotic signals, cell survival prevails (Nagata, 1997; Jarpe et al.,
1998).
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An illustration of this delicate balance between survival and apoptosis
is seen in porcine granulosa cells, wherein treatment with growth factors,
such as FSH or fetal bovine serum (FBS), actually results in apoptosis if the
phosphorylation of ERK1/2 (a survival signal) is inhibited (Shiota et al., 2003).
Conversely, inhibition of the p38 pro-apoptotic pathway prevents peroxideinduced apoptosis in this same model (Shiota et al., 2003). Phosphorylation
of JNK prompts apoptosis of granulosa cells, implicating JNK signaling in
follicular atresia (Peter and Dhanasekaran, 2003). ERK5 enhances
progesterone secretion by granulosa cells, but the effect of ERK5
phosphorylation on granulosa cell fate is not known (Gao et al., 2011).
Overall, ERK1/2 phosphorylation generally prevents apoptosis of granulosa
cells, but phosphorylation of JNK and p38 promote apoptosis and possibly
contribute to follicular atresia.
The PI3K/Akt Pathway
The serine/threonine kinase Akt (also known as protein kinase B; PKB)
was originally discovered as v-Akt, a retrovirus-associated oncogene from the
AKT8 murine retrovirus (Staal, 1977). The molecule Akt is a key player in
cell survival, metabolism, motility and gene expression associated with the
PI3K pathway (Cantley, 2002). This pathway is activated in response to: 1)
phosphorylation of receptor tyrosine kinases (RTKs) by growth factors, 2)
stimulation of G-coupled receptors, and 3) activation of integrins (Fayard et
al., 2005). Ligand-receptor interaction results in the activation of second
messenger PI3K by phosphorylation. Phosphorylation of PI3K can also be
15

achieved by interacting with the protein Ras, which is also associated with the
MAPK pathway (Datta et al., 1999). The activation of PI3Ks further stimulate
second messenger phosphoinosotides by phosphorylation (i.e. converting
phosphatidylinosotide-4-5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5triphosphate (PIP3) (Rameh and Cantley, 1999). The formation of PIP3 then
facilitates recruitment of Akt to the plasma membrane and activates it by
phosphorylation (Fayard et al., 2005).
This pathway and its interaction with the MAPK pathway are relevant
to the fate of granulosa cells and follicular development because within
bovine ovaries, levels of Akt, phosphorylated Akt (p-Akt), ERK and
phosphorylated ERK (p-ERK) are all elevated in dominant follicles compared
to subordinate follicles (Ryan et al., 2007). In addition, inhibition of the PI3K
pathway impairs granulosa cell responsiveness to FSH and IGF stimulation
(Ryan et al., 2008). This suggests both the MAPK and PI3K pathways have a
critical role in the fate of granulosa cells within the follicle, and most likely
influence the selection of dominant versus subordinate follicles during
folliculogenesis.
Fas and the Follicle
A physiologic mechanism of atresia in follicles is the effect of Fasinduced apoptosis of granulosa cells (Hughes et al., 1991; Tilly et al., 1991).
Both Fas and FasL are expressed in ovaries of mammals across most
species, including humans, domesticated livestock and rodents (Dharma et
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al., 2003; Inoue et al., 2006; Kim et al., 1998; Quirk et al., 1995; Quirk et al.,
1998; Vickers et al., 2000). Differential expression of FasL and/or Fas among
granulosa cells of follicles might influence the occurrence of apoptosis and
follicular atresia.
In granulosa cells, Fas expression increases following pretreatment
with the cytokines interferon gamma (IFNy) and tumor necrosis factor alpha
(TNFa), causing the cells to be vulnerable to Fas-induced apoptosis (Quirk et
al., 1998; Porter et al., 2000; Vickers et al., 2000). Inhibition of protein
synthesis (via cycloheximide) also enhances granulosa cell sensitivity to Fasinduced apoptosis (Quirk et al., 1995; Quirk et al., 1998), implying that labile,
anti-apoptotic proteins exist within granulosa cells to prevent apoptosis.
The expression of Fas has been evaluated in bovine follicles across
the estrous cycle; expression of Fas mRNA is highest in granulosa cells of
atretic, subordinate follicles and lowest in preovulatory follicles (Porter et al.,
2000). This suggests one aspect of follicular atresia is the upregulation of
Fas mRNA in granulosa cells. However, it is noteworthy that granulosa cells
of these same atretic follicles in vitro are generally resistant to Fas-induced
apoptosis unless pretreated with cytokines such as IFNy or TNFa (Quirk et
al., 1998; Porter et al., 2001). Additional factors must exist either within the
granulosa cells, or within their follicular environment (i.e., in vivo) to affect
sensitivity to Fas-induced apoptosis.
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Mechanisms that influence Fas expression
In vitro versus in vivo environment could have profound effects on the
expression of the Fas receptor by granulosa cells. Fas expression and
trimerization in response to FasL are both necessary for induction of the Fasinduced apoptotic pathway, but it is currently unclear what cellular
mechanisms regulate Fas expression on the surface of granulosa cells. In
liver epithelial cells (hepatocytes), cytoskeletal intermediate filaments
influence Fas expression and Fas-induced cell signaling (Coulombe and
Omary, 2002). Genetic knockout of the intermediate filament protein, keratin
8 (K8), increases Fas expression and enhances the sensitivity of hepatocytes
to Fas-induced apoptosis (Gilbert et al., 2001). Similarly, our laboratory has
* determined that the absence of keratin 18 (K18) -containing intermediate
filaments makes HeLa cells more sensitve to Fas-induced apoptosis (Sullivan
et al., 2010). Interestingly, hepatocytes of K8-null mice also express less
ERK1/2 and cFLIP compared to hepatocytes of wild-type mice, suggesting
the expression of keratin intermediate filaments, the presence of cFLIP and
the activation of ERK1/2 may together protect the cells from Fas-induced
apoptosis (Gilbert et al., 2004).
Keratin Intermediate Filaments
Intermediate filaments (IFs) were first described by Ishikawa et al. in
1968 as cytoskeletal scaffolds in the nucleus and cytoplasm in metazoans
(Ishikawa et al., 1968; Kim et al., 2007). Together with microtubules and
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microfilaments, IFs comprise the third component of the cytoskeleton of most
cells. Structurally, all IFs are comprised of a central helical rod flanked by Nterminal and C-terminal head and tail domains, respectively; the rod domains
are conserved among subclasses, but terminal domains are conserved
across all IFs (Figure 3) (Fuchs and Weber, 1994).
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The generally understood function of IFs is to provide structural integrity, but
in recent years a more dynamic role for these structures has been suggested,
including the modulation of apoptosis, responsiveness to physiologic stress,
wound healing, facilitating cell growth and mitosis, regulating tissue polarity
and influencing tissue remodeling (Moll et al., 2008).
The keratins are a subclass of IFs occurring as heterodimers
composed of a type I (acidic; numbered 9-20) and type II (basic; numbered 18) filament. Keratin 8/18 (K8/K18) IFs are considered characteristic of simple
epithelia (including granulosa and theca cells of follicles), immortalized cell
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lines and carcinomas; and they are the first keratin proteins expressed during
embryonic development (Moll et al., 1982; Jackson et al., 1980).
In recent years, investigators have discovered many novel functions for
keratin IFs beyond their well-accepted role in providing structural support to
the cell. For instance, there is current thinking that K8/K18 IFs sequester the
activity of intracellular kinases, especially following cellular stress. Essentially
the filaments provide an abundance of serine residues within their structure,
serving as phosphorylation substrates or “phosphate sponges” for stressactivated kinases (e.g., Akt). This action prevents the activation of
downstream pathways by these stress kinases that might otherwise lead to
apoptosis (Ku and Omary, 2006). The solubilization and polymerization
activities of the keratins are directly influenced by this serine phosphorylation
in the head and tail domains of K8 (Ser-23/Ser-73/Ser-431) and K18 (Ser33/Ser-52) (Omary et al., 1998; Coulombe and Omary 2002; Owens and
Lane, 2003; Omary et al., 2006). In this manner, the sheer abundance of the
filaments with their multiple phosphorylation sites re-direct the activities of
apoptotic kinases away from downstream death-signaling mechanisms (Ku
and Omary, 2001). Interestingly, K8 and K18 also have phosphorylation sites
that are recognized by MAPK (Galarneau et al., 2006) and cell cycle
progression 14-3-3 proteins (Liao and Omary, 1996) The Ser74 and Ser431
phosphorylation sites on K8 are associated with ERK1/2 (Ku and Omary,
1997) and p38 (Ku et al., 2002). Liao and Omary demonstrated that K8/K18
hyperphosphorylation during the S and G2/M phases of the cell cycle result in
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14-3-3 protein binding, that in turn, activate PI3K and MAPK pathways (Liao
and Omary, 1997). Thus K8/K18 IFs within cells may activate cell
proliferation pathways in response to stress signals as a protective
mechanism.
Beyond these measures, K8/K18 filaments protect cells from
apoptosis, stress and injury by impairing the cell surface expression of Fas
and the downstream activation of caspases (Gilbert et al., 2001). Inhibition of
caspase activation occurs, in part, by enhancing the expression and
activation of the anti-apoptotic proteins cFLIP and ERK1/2 (Gilbert et al.,
2004). Genetic knock-down of K8 reduces endogenous c-FLIP expression
and decreases phosphorylation of ERK1/2, making mouse hepatocytes three
to four times more sensitive to FAS-induced apoptosis than their wild-type
counterparts (Gilbert et al., 2001; Gilbert et al. 2004). Thus, K8/K18 filaments
are thought to provide resistance to Fas-induced apoptosis by suppressing
Fas expression and caspase activation, while concomitantly activating
survival pathways and promoting cell proliferation.
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K8/K18 Filaments and Granulosa Cells
Keratins are expressed in granulosa cells of bovine follicles across the
developmental stages, but their role in folliculogenesis is unknown
(Czernobilsky et al., 1985; Gall et al., 1992; Santini et al., 1993; Townson et
al., 2010; van den Hurk et al., 1995). The K8/K18 filaments are expressed in
granulosa cells of the follicle, but their expression in atretic follicles is less
evident than growing or recently ovulated follicles (Townson et al., 2010).
Additionally, the relative expression of K8/K18 filament expression in
granulosa cells is inversely proportional to the number of cells undergoing
apoptosis as observed by Cyto-DEATH immunodetection (Townson et al.,
2010). This suggests the onset of apoptosis of granulosa cells and the
occurrence of follicular atresia are associated with a loss of K8/K18 filaments.
Others have shown Fas-induced apoptosis in granulosa cells is augmented
by inhibition of cFLIP and inactivation of ERK1/2 (Matsuda et al., 2008; Shiota
et al., 2003). At present, however, no one has determined whether K8/K18
filaments modulate Fas-induced apoptosis of granulosa cells of follicles
through cFLIP expression and/or ERK1/2 phosphorylation as has been
described in simple epithelial cells of other tissues (Gilbert et al., 2001; Gilbert
et al., 2004).
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Objectives and Hypotheses

The present study proposes there is a functional connection between
K8/K18 filament expression, apoptosis-inhibition and survival signaling in
granulosa cells influencing their vulnerability to apoptosis. The current study
investigated the above-described relationships in the context of Fas-induced
apoptosis and follicular atresia.
The objectives of the study were to 1) determine the relative
expression of K8/K18 filaments in granulosa cells of human and bovine origin
and 2) identify putative cellular mechanisms by which granulosa cells resist
Fas-induced apoptosis, specifically determining whether or not K8/K18
filaments have a role in this protection.
We postulated K8/K18 expression, in part, accounts for the relative
resistance of granulosa cells to Fas-induced apoptosis by: 1) decreasing the
cell surface expression of Fas, 2) enhancing apoptosis-inhibiting proteins, and
3) activating intracellular pro-survival pathways.
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CHAPTER I

INVESTIGATION OF THE ROLE OF KERATIN 8/18 INTERMEDIATE
FILAMENTS ON THE FATE OF GRANULOSA CELLS

Introduction
Infertility is an ever-growing concern of today's agricultural industry
(Lucy, 2001). For dairy operations, profitability depends upon the ability of
the cow to give birth to a live calf each year. Follicular atresia is one aspect
of ovarian function that contributes to poor reproductive performance and may
result in infertility (Lucy, 2002).
Apoptosis of granulosa cells is contributing factor to follicular atresia
within the ovary, preventing follicle maturation and ovulation, and possibly
impairing fertility in females (Hughes and Gorospe, 1991; Tilly et al., 1991).
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The extrinsic pathway of apoptosis, activated by cytokines and other
influences external to the targeted cell, is thought to contribute to the process
of follicular atresia (Townson and Combelles, 2012). The cytokine Fas ligand
(FasL) and its corresponding receptor, Fas, for instance, are elevated in
atretic follicles compared to healthy follicles (Kim et al., 1998; Vickers et al.,
2000; Porter et al., 2001; Inoue et al., 2006). However, cultured granulosa
cells are typically resistant to Fas-induced apoptosis unless first pretreated
with tumor necrosis factor (TNF) and interferon-gamma (IFN) (Quirk et al.,
1995), which is thought to increase the surface expression of Fas (Quirk et
al., 1998). It is therefore conceivable that Fas-induced apoptosis of granulosa
cells contributes to follicular atresia, and that cytokines such as TNF and IFN
facilitate this process.
The targeted and selective loss of granulosa cells by apoptosis without
accompanying collateral damage to adjacent cells is a characteristic aspect of
follicular atresia. Apoptosis is also a hallmark of the FasL-Fas system, by
which the immune system establishes immune tolerance and the elimination
of lymphocytes targeted against self-antigens. The cytokines TNF, TRAIL,
and their corresponding receptors are additional influences, similar to FasL
and Fas, which potentially trigger apoptosis and induce follicular atresia in
certain species (Prange-Kiel et al., 2001; Xiao et al., 2002; Inoue et al., 2003).
However, beyond these hormonal influences on granulosa cell viability within
follicles, there are structural, cytoskeletal influences to consider. In the last
decade, for instance, a number of studies have implicated the cytoskeletal
25

elements (i.e., microtubules, microfilaments, and intermediate filaments) as
profoundly affecting follicular growth, potentially impairing ovulation, and
causing cystic follicles (Salvetti et al., 2004; Ortega et al., 2007; Salvetti et al.,
2010 ).

Microtubules, microfilaments, and intermediate filaments collectively
influence the activities of most cells, including the granulosa cells within
follicles. Microtubules regulate steroidogenesis (Chen et al., 1994), but they
also determine cell shape and affect cytoplasmic movement of organelles
within granulosa cells (Sutovsky et al., 1994). Microfilaments drive granulosa
cells toward differentiation (i.e., luteinization) (Amsterdam and Rotmensch,
1987) and facilitate death (Amsterdam et al., 1997). Under apoptotic
conditions, for example, microfilaments within granulosa cells undergo
rearrangement to compartmentalize the steroidogenic machinery to the
perinuclear region while directing other proteolytic activities to the apoptotic
bodies (Amsterdam et al., 1997). The intermediate filaments, including
vimentin, the cytokeratins, and desmin, influence cell mitosis, follicular
atresia, and de-differentiation of cells of the follicle (van den Hurk et al., 1995;
Khan-Dawood et al., 1996; Loffler et al., 2000). Most recently, our laboratory
has identified intermediate filaments, particularly keratin 8 and keratin 18
(K8/K18) filaments, as possible intrinsic modulators of granulosa cell
apoptosis during folliculogenesis (Townson et al., 2010).
The K8/K18 filaments are considered “stress filaments” characteristic
of most simple epithelia, immortal cell lines and carcinomas. They provide
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structural integrity and mechanical stability to cells via cell-cell junctions (Moll
et al., 2008; Waschke, 2008). Recently, dynamic features of these filaments
have become evident, suggesting the K8/K18 filaments also modulate death
signaling by regulating cytokine receptors, enhancing anti-apoptotic proteins
and activating intracellular survival pathways (Gilbert et al., 2001; Marceau et
al., 2001; Eriksson et al., 2009; Sullivan et al., 2010). Genetic knockdown of
K8 in mouse hepatocytes, for instance, increases the cell surface expression
of Fas and up-regulates caspase activation (Gilbert et al., 2001). The
expression of the anti-apoptotic protein cellular flice inhibitory protein (cFLIP;
also known as CFLAR) and the phosphorylation of extracellular regulated
kinases 1 and 2 (ERK1/2) are also impaired in these hepatocytes (Gilbert et
al., 2004). As a result, the K8-null hepatocytes are three to four times more
sensitive to Fas-induced apoptosis (Gilbert et al., 2001; Gilbert et al., 2004).
The K8/K18 filaments within granulosa cells of follicles might orchestrate
similar aspects of cellular fate, possibly enabling the cells to evade Fasinduced apoptosis by impairing Fas expression, augmenting cFLIP
expression and/or ERK1/2 phosphorylation.
The objectives of the current study were to investigate the above
described possibilities by: 1) determining the relative expression of K8/K18
intermediate filaments within granulosa cells, 2) identifying cellular
mechanisms by which granulosa cells resist Fas-induced apoptosis, and 3)
determining if K8/K18 filaments have a role in this resistance. For the
majority of this work, immortal cells established from a granulosa cell tumor,
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the KGN cell line, were utilized. The cells retain many physiological attributes
of granulosa cells, including responsiveness to FSH through a functional FSH
receptor (Nishi et al., 2001). Additional experiments with primary cultures of
granulosa cells derived from bovine ovarian follicles were then initiated for
comparative purposes.
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Materials and Methods

Animal Care and Use
Follicles from bovine ovaries were obtained from local slaughterhouse
facilities or research cows at the Fairchild Dairy Teaching and Research
Center. A protocol for this purpose was approved by the UNH Animal Care
and Use Committee (IACUC) # 120104.
Cells and culture conditions
KGN cell line
The human granulosa cell tumor line, KGN, was generously provided
by Dr. Fukuzawa (RIKEN Cell Bank, Koyadai, Japan) through our
collaborator, John S. Davis (University of Nebraska Medical Center, Omaha,
NE). The KGN cells were maintained in DMEM/F12 (1:1; Life Technologies,
Grand Island, NY) supplemented with 10% FBS (JRH Biosciences, Lenexa,
KS) at 37°C with 5% CO2 and 95% air, with 95% humidity.
Primary bovine granulosa cells
The bovine ovaries obtained from slaughterhouse facilities and the
Fairchild Dairy were transported to the laboratory at 25°C in sterile saline, and
then rinsed in ethanol, Betadine solution and PBS before dissecting all
follicles s 10 mm in DMEM/F12 + 2 pL/mL gentamicin. Follicular fluid from
each of the follicles was removed by aspiration, the follicles were bisected
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and then gently scraped to release the granulosa cells. The granulosa cells
were washed three times for 10 minutes at 25 °C at 500, 250 and 175 x g to
remove red blood cells. Once washed, the cells were counted using the
Trypan Blue exclusion method then seeded in plastic cultureware and
maintained in DMEM/F12 (1:1; Life Technologies, Grand Island, NY)
supplemented with 10% FBS (JRH Biosciences, Lenexa, KS) at 37°C with 5%
C 0 2 and 95% air, with 95% humidity.
Culture conditions
The granulosa cells (KGN and bovine) were either seeded in 96-well
plates (BD Biosciences, San Jose, CA) at 1x104 cells/well for Caspase-Glo
3/7, CellTiter 96 and In-Cell Western assays, seeded in 6-well plates
(Corning, Corning, NY) at 3x105 cells/well for immunoblotting experiments or
seeded in microchamber slides (Nunc, Rochester, NY) at 1x104 cells/well and
T75 or T150 vented flasks (BD Biosciences, San Jose, CA) at 5x105 cells and
1x106 cells/flask, respectively, for immunofluorescence and flow cytometry
analysis. In all cases, the granulosa cells were grown to 70% confluency
prior to the onset of treatments. For siRNA experiments, conditioned culture
medium was exchanged for antibiotic-free DMEM/F12 medium + 10% FBS,
and immediately prior to cytokine treatments, exchanged for again for serumfree DMEM/F12 medium.
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Immunofluorescent visualization of K8/K18 intermediate filaments
Following culture, granulosa cells grown in microchamber slides were
rinsed twice with PBS and then fixed for 20 minutes at room temperature with
2% paraformaldehyde (PFA) in a microtubule-stabilizing buffer (100 mM
HEPES, pH 7.31; 1 mM MgS04-7H20; 1 mM EGTA; 0.2% Triton X-100).
Subsequently, the fixed cells were permeabilized for 20 minutes in ice-cold
100% methanol. After permeabilization, the cells were washed three times
with PBS + 0.1% BSA and labeled with mouse anti-human K18-FITCconjugated antibody (CY90; Sigma-Aldrich, St. Louis, MO) diluted 1:100 in
PBS + 1% BSA and Rhodamine Phalloidin (Life Technologies; Grand Island,
NY) diluted 1:400 in PBS + 1% BSA for 1 hour at 37°C in a humidified
chamber. In previous work, the dimerization of K18 protein with K8 protein to
form a K8/K18 heterodimeric filament bovine granulosa cells and luteal cells
was verified (Townson et al., 2010; Duncan et al., 2012). Thus,
immunological targeting of K18 for the detection of K8/K18 filaments in the
granulosa cells was considered adequate. For a negative control, the cells
were exposed to a mouse anti- human IgG-FITC-conjugated antibody
(Sigma-Aldrich, St. Louis, MO) diluted 1: 100 in PBS + 1% BSA as a
substitute for the primary antibody. The slides were washed three times with
PBS + 0.1% BSA, then mounted on coverslips with ProLong® Gold Antifade
reagent containing DAPI (Life Technologies, Grand Island, NY).
Photographic Images of the K8/K18 filament immunostaining were collected
using an Olympus BH2-RFC upright fluorescent microscope (Center Valley,

PA), Qimaging QICAM monochrome digital camera (Surrey, BC, Canada)
and ImagePro Insight software (Media Cybernetics, Bethesda, MD).
Flow cytometric quantification of Fas surface and K18 expression
Cultured cells were trypsinized using Cellgro 0.25% Trypsin-EDTA
(Corning, Corning, NY) and fixed for 20 minutes at room temperature with 2%
paraformaldehyde in a microtubule-stabilizing buffer (100 mM HEPES, pH
7.31; 1 mM MgS04-7H20 ; 1 mM EGTA; 0.2% Triton X-100). For Fas surface
staining, the cells were stored in paraformaldehyde; for K18 staining, the cells
were fixed with paraformaldehyde, permeabilized in ice-cold 70% ethanol for
20 minutes and then stored at -20°C. For antibody labeling, both types of cell
preparations were washed three times with PBS + 0.1% BSA, and then either
labeled overnight at 4°C with mouse anti-human Fas (CH11; EMD Millipore,
Darmstadt, Germany) antibody diluted to 20 pg/mL in 10% normal goat serum
+ PBS + 1% BSA or labeled for 1 hour at 37°C with mouse anti-human K18FITC-conjugated antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:100 in
PBS + 1% BSA. Separate preparations labeled with mouse anti-human IgGFITC-conjugated antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:100 in
PBS + 1% BSA served as negative controls. For cells labeled with Fas
antibody, the cells were subsequently washed three times with PBS + 0.1%
BSA, and then incubated for 1 hour at 37°C with Alexa Fluor® 488 (Life
Technologies, Grand Island, NY) diluted 1:200 in 10% NGS + PBS + 1%
BSA. For both Fas- and K18-labeled cells, the cells were washed three times
with PBS + 0.1% BSA and then analyzed using a 4 color, dual laser FACS
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Calibur Flow Cytometer (BD Biosciences, San Jose, CA), quantifying 10,000
cells. Data were collected using CellQuest software (BD Biosciences; San
Jose, CA) and then analyzed using WinMDI (Joe Trotter; Purdue University,
West Lafayette, IN) to quantify the cell surface expression of Fas and K8/K18
filament expression.
Induction of Fas-mediated apoptosis
Granulosa cells were cultured and exposed to pretreatments of
cycloheximide (CHX; 0.25 pg/mL; Sigma-Aldrich, St. Louis, MO), the MEK1/2
inhibitor PD98059 (30 pM; Cell Signaling Technologies, Danvers, MA) or the
Akt inhibitor Wortmannin (100 nM; EMD Millipore, Darmstadt, Germany) for 2
hours in serum-free culture medium. After pretreatment, the cells were
exposed to a Fas-activating antibody (1 pg/mL; clone CH11; EMD Millipore,
Darmstadt, Germany) or Staurosporine (1 pM; MP Biomedical, Santa Ana,
CA) as a positive control, to induce apoptosis. The cells were exposed to the
above treatments for 8 and 24 hours, at which time the incidence of apoptosis
was measured by caspase 3/7 activity using a Caspase-Glo® 3/7 Assay or a
cell viability Cell Titer 96 (MTS) assay. These assay were conducted
according to the manufacturer’s instructions (Promega, Madison, Wl).
Immunoblot analysis for Fas. cFLIP. cleaved PARP and B-Actin
Nearly confluent cells from the above-described experiments were
washed twice with ice-cold PBS and harvested in lysis buffer (10mM TrisHCL; 1mM EDTA; 1mM EGTA; 100mM NaCI; 1% Triton X-100; 0.5% Nonidet
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P-40, pH 7.4) containing kinase, protease and phosphatase inhibitor cocktails
(Sigma-Alrich, St. Louis, MO). The cells were scraped, collected, and
sonicated for 3 seconds then resuspended in 2X SDS loading buffer (100 mM
Tris-CI, pH 6.8 + 4% SDS, 0.2% bromophenol blue, 20% glycerol, 200 mM
DTT) and denatured at 95°C for 5 minutes. Total cellular proteins were
separated by 12.5% SDS-PAGE and then transferred to polyvinylidene
difluoride (PVDF) membranes (EMD Millipore,Darmstadt, Germany).
Immunoblotting was performed using antibodies to detect human cFLIP (also
known as CFLAR) (rabbit anti-human CFLAR; Sigma Aldrich, St. Louis, MO)
and human Fas (clone C-20; Santa Cruz Biotechnology, Santa Cruz, CA) to
determine the effect of cytokine and inhibitors on expression of cFLIP and
Fas. Membranes were stripped and reprobed for cleaved human poly ADP
ribose polymerase (PARP) (# 9542, Cell Signaling Technology, Danvers,
MA), involved in DNA depletion and DNA repair during cell death, to validate
apoptotic activity and P-actin (clone AC-15; Sigma Aldrich, St. Louis, MO) for
normalization of protein loading.
Short interfering RNA (siRNA) knockdown of K8/K18
Granulosa cells were transiently transfected with 6-10 pmol KRT8 and
KRT18 siRNA constructs according to RefSeq numbers: NM_001033610.1
and NM_001192095.1 (siRNA ID S444557 and S444560; Silencer® Select
siRNA, Ambion Inc., Foster City, CA).

Transfection was achieved using

Lipofectamine™ RNAiMAX in OptiMEM® Reduced Serum Media for final 60100 nM RNAi duplexes according to the manufacturer’s instructions (Life
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Technoloies, Grand Island, NY). Briefly, cells were grown to 70% confluency
then switched to antibiotic-free DMEM/12 + 10% FBS before siRNALipofectamine duplexes were introduced. The cells were also exposed to a
non-targeting siRNA (Silencer® Select Negative Control #1; Ambion Inc.,
Foster City, CA) and Lipofectamine™ alone as negative controls. Optimal
siRNA and Lipofectamine concentrations were established and validated
using an In-Cell Western assay according to the manufacturer’s instructions
described briefly below (Cell Signaling Technology, Danvers, MA; LI-COR®,
Lincoln, NE).
Validation of K8/K18 knockdown (In-Cell Western Assay)
After 72 hours of transfection, the siRNA duplexes were removed from
the culture medium, the cells were washed and then fixed and permeabilized
for 10 minutes in ice-cold 100% methanol. Following permeabilization, the
cells were washed three times in PBS, then exposed to blocking for one hour
at room temperature (Blocking Buffer: PBS + 5% normal goat serum + 0.3%
Triton X-100). Subsequently, the cells were incubated overnight at 4°C with a
primary antibody cocktail of mouse anti- human K18 (CY90; Sigma-Aldrich,
St. Louis, MO) and rabbit anti-human P-Actin (13E5, Cell Signaling
Technolgy, Danvers, MA) diluted 1:800 and 1:200, respectively, in antibody
dilution buffer (PBS /1% BSA / 0.3% Triton X-100), respectively. After
washing three times for five minutes each in PBS, the granulosa cells were
incubated for 1 hour at room temperature in the dark with a cocktail of
fluorochrome-conjugated secondary antibodies (goat anti-mouse IgG H+L
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DyLight 800 and goat anti- rabbit IgG H+L DyLight 680, Cell Signaling
Technology, Danvers MA) diluted 1:2000 and 1:1000, respectively, in
antibody dilution buffer. After washing three times for five minutes each,
plates containing the cells were scanned on the LI-COR® Odyssey® Classic
Infrared Imaging scanner (LI-COR, Lincoln, NE) at 680 and 800 nm in the
infrared color spectrum. Staining intensity for K18 was normalized to staining
intensity for p-actin using the provided scanning (LI-COR, Lincoln, NE)
(protocol adapted from In-Cell Immunofluoresence protocol, Cell Signaling
Technology, Danvers, MA). Expression of K18 (relative to P-actin) provided a
method to normalize staining intensity across treatments to account for
differences in seeding density, possibly as a result of cytotoxicity.
Statistical analysis
All experiments were repeated three to six times, using a fresh aliquot
of cells (KGN) or bovine follicles for each experiment. Data were analyzed
initially by one-way or two way analysis of variance (ANOVA), followed by a
Tukey’s post-test for multiple comparisons. Differences among means at a
value of P<0.05 were considered statistically significant.
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Results
K18 and B-Actin expressed in KGN cells
Immunofluorescence for K18 and p-actin indicated KGN cells express
abundant K8/K18 and p-actin filaments (Figure 4).

F ig u re 4 R epresentative im age of im m unofluorescent staining in cultured K G N cells. (A )
D A P I, (B ) K 18 filam ents stained with F IT C (green), (C ) P-Actin stained with Phalloidin (red)
and (D ) m erged im age (2 0 0 X , bars represent 2 0 microns).
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High K18 expression but low Fas surface expression on KGN Ceils
Flow cytometry analysis confirmed ~91% of the KGN cells express K18
protein, yet only 24% of the cells express Fas on the cell surface (Figure 5).
Mean fluorescent intensity measures (an indication of fluorescence per cell)
were similarly high for K18 expression, but low for Fas expression (Fig. 5D).
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Inhibition of protein synthesis sensitizes KGN cells to Fas-induced
apoptosis

KGN cells exposed to the protein synthesis inhibitor, CHX, prior to
treatment with the Fas activating antibody, CH11, augmented Fas-induced
apoptosis (Figure 6). Treatment with CH11 or CHX alone, however, had no
effect. Inhibition of de novo protein synthesis with CHX provoked a 10-fold
increase in Fas-induced apoptosis, similar to the chemotherapeutic agent
Staurosporine.
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F ig u re 6 Fas-m ediated apoptosis in cultured K G N cells, quantified by ca s p a s e 3 /7 activity
(RLU; ± S E M ) following protein synthesis inhibition. T h e cultures w ere exposed to protein
synthesis inhibitor C H X (0 .2 5 pg/m L) for 10 hours and F as (1 pg/m L activating antibody
C H 1 1) for a period of 8 hours (n = 6 experim ents; different letters denote differences, p< 0 .0 5 ).
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Fas and cFLIP expression following Fas-induced apoptosis of KGN cells
No overt changes in the expression of Fas or cFLIP protein were
observed following exposure of cultured KGN cells to CHX or CH11 (Fas
activating antibody) (Figure 7A). Conversely, Fas-induced apoptosis by these
treatments was confirmed by detection of PARP and cleaved PARP (Figures
7A &B). Confirming the Caspase-Glo 3/7 assay results above, the combined
treatment of CHX+CH11 caused a 2-fold increase in cleaved PARP
compared to the control cultures.
B.
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F ig u re 7 Im m unodetection of Fas, cFLIP , cleaved P A R P an d p-Actin following exposure to th e
protein synthesis inhibitor C H X (0 .2 5 pg/m L) and Fas stimulation (1 pg/niL activating antibody
C H 1 1 ) in K G N cells. A . Representative im munodetection of Fas, c F L IP , cleaved P A R P and PActin following treatm ents. B. A v e ra g e expression of Fas, cF LIP and cleaved P A R P (± S E M )
relative to p-Actin following treatm ent (n=3 experim ents, different letters denote differences,
p <0.05).
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Inhibition of ERK1/2 and Akt fails to sensitize KGN cells to Fas-induced
apoptosis
Inhibition of the MAPK pathway had no effect on Fas-induced
apoptosis (Figure 8). Conversely, inhibition of the PI3K pathway provided
modest protection from Fas-induced apoptosis (Figure 9).
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F ig u re 8 Induction of Fas-m ediated apoptosis in cultured K G N cells, quantified by
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P < 0 .0 5 ).
□ Without Wortmannin
■ With Wortmannin

Control

CHX + Fas

Staurosporine

F ig u re 9 Induction of Fas-m ediated apoptosis in cultured K G N cells, quantified by
m etabolic activity (M T S assay; ± S E M ). T h e cultured cells w e re exposed to A kt inhibitor
W ortm annin (1 0 0 nM ) and C H X for 2 6 hours and Fas activating antibody for 2 4 hours
(n=3 experim ents; different letters denote differences am ong treatm ents, apostrophes
denote differences between without and with W ortm annin within treatm ent groups;
P < 0 .0 5 ).
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Genetic downrequlation of K8/K18 filaments (siRNA) enhances Fasinduced apoptosis of granulosa cells
For the KGN cells, optimized treatment conditions after 72 hours of
transfection were 10 pmol KRT8 and KRT18 siRNA combined with 0.3 pL
Lipofectamine RNAiMAX (100 nM siRNA duplex) (Figure 10A), which resulted
in 30% downregulation of K18 expression compared negative controls (Figure
10B). For primary cultures of bovine granulosa cells, optimal transfection
conditions consisted of 6 pmol KRT18 siRNA combined with 0.3 pL
Lipofectamine RNAiMAx (60 nM siRNA duplex), which reduced K18
expression by 65% expression (Figure 10B).
Bovine
Granulosa cells

KGN cells

10 pmol KRT8 +
KRT18 SiRNA

6 pmol KRT18 SiRNA

10 pmol Negative
Control siRNA

6 pmol Negative
Control siRNA

Negative Control

Negative Control

B.
1.2

■ KGN
□ Bovine GC

Negative Control Negative Control siRNA

KRT8/13 siRNA

F ig u re 1 0 Im m unodetection of K 18 expression in granulosa cells mock transfected or
transfected with 100 nM (K G N cells) or 6 0 nM (bovine granulosa cells) s iR N A to K R T 8
and18. A . R epresentative In-Cell W e s te rn dual detection of K 18 protein (g reen ) and (3-Actin
protein (red) following K R T 8 /1 8 siR N A . N egative controls consisted of cells transfected with
equim olar concentrations of a non-targeting siR N A or Lipofectamine™ alo n e B.
Quantification o f K18 relative to (3-actin expression following K R T 8 /1 8 -s iR N A transfection.
Apostrophes denotes differences within cell types (P < 0 .0 5 ; K G N , n=3 experim ents; b G C , n=1
experim ent).
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Genetic knock-down of the K8/K18 filaments with siRNA enhanced
Fas-induced apoptosis compared to negative control (i.e. scrambler siRNA) in
KGN cells (Figure 11).
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■ With Fas
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Negative Control siRNA
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F ig u re 11 Induction of F as-m ediated apoptosis m easured by casp ase 3 /7 activity (R LU;
± S E M ) following siR N A transfection with a negative control s iR N A and K R T 8 and 18 siR N A
in cultured K G N cells (n =3 experim ents; different letters denote differences, P < 0 .0 5 ).
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Discussion
During follicular atresia, discrete populations of granulosa cells within
the follicle undergo apoptosis. However, the mechanisms regulating the cellspecificity of this process are unclear (Tilly et al., 1991). Previously, we
suggested the prevalence and the cell-specificity of K8/K18 filaments within
the granulosa cells might influence their vulnerability to apoptosis (Townson
et al., 2010). Here, we demonstrated, for the first time, that granulosa cells
are indeed more sensitive to Fas-induced apoptosis when K8/K18 filament
expression is impaired. The reduction of K8/K18 filament expression in the
granulosa cells was achieved using siRNA transfection, but similar effects
have been observed in other types of non-ovarian epithelial cells in knockout
mouse models or immortal cell lines (Caulin et al., 2000; Gilbert et al., 2001;
Gilbert et al., 2004; Sullivan et al., 2010). In the K8 knockout mouse, for
example, hepatocytes lacking K8/K18 filaments express more Fas on the cell
surface, but also express less cFLIP, ERK1/2 and Akt intracellularly, which
make them two times more sensitive to Fas-induced apoptosis than
hepatocytes from wild-type mice. Essentially the K8/K18 filaments are
thought to orchestrate the fate of epithelial cells by suppressing death
signaling, while enhancing survival signals (Gilbert et al., 2001; Gilbert et al.,
2004). The K8/K18 filaments within granulosa cells of follicles might similarly
dictate cellular fate, possibly by enabling the cells to evade Fas-induced
apoptosis through similar mechanisms.
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The objectives of the current study were to determine the expression of
K8/K18 filaments in granulosa cells, identify possible protective mechanisms
by which granulosa cells resist apoptosis, and determine if K8/K18 filaments
have a role in such protection. The results of this study support the concept
that K8/K18 filaments influence granulosa cell fate, but whether they augment
cFLIP expression and/or downstream survival signaling remains unclear.
Both KGN cells and primary cultures of bovine granulosa cells abundantly
express K8/K18 filaments, and this abundance of filament expression was
accompanied by a corresponding lack of Fas expression, at least in KGN
cells. Whether or not these factors alone prevented Fas-induced apoptosis is
uncertain, but our overall observations confirm those of previous studies.
Namely, others have shown that cultured granulosa cells are extremely
resistant to Fas-induced apoptosis (Quirk et al., 1998; Mezzanzanica et al.,
2004; Quirk et al., 2004; Matsuda et al., 2008). The current study also
confirmed reports of others (Quirk et al., 1998; Matsuda et al., 2008) that
cultured granulosa cells express labile protein(s), which in part provide
protection against Fas-induced apoptosis. The cells are resistant to Fasinduced apoptosis unless pretreated with a protein synthesis inhibitor such as
CHX (Quirk et al., 1998), or exposed to cytokines in combination with Fas
ligand, such asTNF and IFN (Quirk etal., 1998; Porter etal., 2001). In the
current work in which CHX augmented Fas-induced apoptosis, there was no
effect of CHX on the anti-apoptotic protein, cFLIP, or the expression of total
Fas as detected by immunoblot analysis. This implies that other labile
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survival protein(s), besides cFLIP and Fas, are expressed by granulosa cells
to protect them from Fas-induced apoptosis.
Using KGN cells, we explored the possibility that signaling through
MAPK and PI3K pathways (growth and stress activated pathways,
respectively) might prevent Fas-induced apoptosis. Inhibition of the MAPK
pathway, using the ERK1/2 inhibitor, had no clear effect on Fas-induced
apoptosis. Surprisingly, inhibition of the PI3K pathway, using the Akt inhibitor,
Wortmannin, actually enhanced the metabolic activity of the KGN cells,
suggesting that although this pathway had no effect on Fas-induced
apoptosis, other pathways affecting cellular metabolism become activated in
response to Akt inhibition. Nevertheless, granulosa cell susceptibility to Fasinduced apoptosis is evidently not governed by the ERK1/2 or Akt pathways.
To determine overall whether K8/K18 filaments protect granulosa cells
from Fas-induced apoptosis, the expression of the filaments was
experimentally impaired using siRNA constructs. Knockdown of K8/K18
expression was evident in both KGN cells and primary cultures of bovine
granulosa cells, although the KGN cells required a higher concentration of
siRNA to achieve measurable knockdown. These cells also appeared to be
more tolerant of siRNA transfection than the primary cultures of bovine
granulosa cells. For the bovine granulosa cells, the In-Cell Western assays
revealed cytotoxicity effects, evident from lower cell density following KRT18
siRNA transfection compared to those cells transfected with the non-targeting
(i.e. scrambler) siRNA. Basal caspase activity (a measure of non-targeting
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siRNA -induced apoptosis) was also higher in the primary cultures of
granulosa cells compared to KGN cell cultures. However, both the KGN cells
and bovine granulosa cells became vulnerable to Fas-induced apoptosis
following siRNA knockdown, providing the first evidence that K8/K18
filaments influence granulosa cell resistance to apoptosis. The cellular
mechanisms responsible for this protection (i.e., Fas reception and trafficking,
activation of intracellular survival signals, etc.), however, remain unknown.
In conclusion, the abundance of K8/K18 intermediate filaments in
granulosa cells provide a plausible cellular mechanism to prevent Fasinduced apoptosis, possibly by impairing Fas trafficking and/or activating
downstream, intracellular survival signals. Here, we have provided evidence
that labile protein(s), potentially associated with the K8/K18 filaments, provide
resistance to apoptosis, while other downstream protective mechanisms await
additional investigation. Similar mechanisms have been observed in
epithelial cells of non-reproductive origin, notably hepatocytes (Gilbert et al.,
2001; Gilbert et al., 2004) and HeLa cells (Sullivan et al., 2010), suggesting
the influence of cytoskeletal structure on Fas-induced apoptosis may be more
universal than previously thought. In the context of the current work, the
existence of K8/K18 filaments within granulosa cells of ovarian follicles have
relevance to aspects of follicular atresia and the selection of follicles for
ovulation. These insights have some bearing on therapeutic strategies that
might enhance follicular growth and health within the ovary, thus leading to
overall improvement in female fertility.
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